Foster & Motley Inc Bristol Myers Squibb CO Transaction History

Foster & Motley Inc

  • $1.58 Billion
  • Q3 2024

A detailed history of Foster & Motley Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Foster & Motley Inc holds 26,158 shares of BMY stock, worth $1.51 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
26,158
Previous 29,508 11.35%
Holding current value
$1.51 Million
Previous $1.23 Million 10.45%
% of portfolio
0.09%
Previous 0.08%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024
SELL
$39.66 - $51.75 $132,861 - $173,362
-3,350 Reduced 11.35%
26,158 $1.35 Million
Q2 2024

Aug 02, 2024
SELL
$40.25 - $52.99 $33,447 - $44,034
-831 Reduced 2.74%
29,508 $1.23 Million
Q1 2024

Apr 18, 2024
SELL
$47.98 - $54.4 $181,028 - $205,251
-3,773 Reduced 11.06%
30,339 $1.65 Million
Q4 2023

Feb 01, 2024
SELL
$48.48 - $57.85 $483,878 - $577,400
-9,981 Reduced 22.64%
34,112 $1.75 Million
Q3 2023

Oct 24, 2023
SELL
$57.89 - $64.73 $252,400 - $282,222
-4,360 Reduced 9.0%
44,093 $2.56 Million
Q2 2023

Aug 08, 2023
BUY
$63.71 - $70.74 $256,496 - $284,799
4,026 Added 9.06%
48,453 $3.1 Million
Q1 2023

May 09, 2023
BUY
$65.71 - $74.53 $870,066 - $986,851
13,241 Added 42.46%
44,427 $3.08 Million
Q4 2022

Feb 09, 2023
BUY
$68.48 - $81.09 $225,915 - $267,515
3,299 Added 11.83%
31,186 $2.24 Million
Q3 2022

Nov 04, 2022
BUY
$0.13 - $76.84 $466 - $275,548
3,586 Added 14.76%
27,887 $1.98 Million
Q2 2022

Aug 09, 2022
BUY
$72.62 - $79.98 $473,990 - $522,029
6,527 Added 36.72%
24,301 $1.87 Million
Q1 2022

Apr 28, 2022
BUY
$61.48 - $73.72 $28,526 - $34,206
464 Added 2.68%
17,774 $1.3 Million
Q4 2021

Jan 25, 2022
SELL
$53.63 - $62.52 $342,213 - $398,940
-6,381 Reduced 26.93%
17,310 $1.08 Million
Q3 2021

Oct 29, 2021
BUY
$59.17 - $69.31 $183,841 - $215,346
3,107 Added 15.09%
23,691 $1.4 Million
Q2 2021

Jul 20, 2021
BUY
$61.91 - $67.42 $459,000 - $499,851
7,414 Added 56.29%
20,584 $1.38 Million
Q1 2021

Apr 26, 2021
BUY
$59.34 - $66.74 $227,568 - $255,947
3,835 Added 41.08%
13,170 $831,000
Q4 2020

Feb 01, 2021
BUY
$57.74 - $65.43 $12,702 - $14,394
220 Added 2.41%
9,335 $579,000
Q3 2020

Oct 19, 2020
SELL
$57.43 - $63.64 $22,282 - $24,692
-388 Reduced 4.08%
9,115 $550,000
Q2 2020

Jul 20, 2020
SELL
$54.82 - $64.09 $98,072 - $114,657
-1,789 Reduced 15.84%
9,503 $559,000
Q1 2020

Apr 21, 2020
BUY
$46.4 - $67.43 $153,584 - $223,193
3,310 Added 41.47%
11,292 $629,000
Q4 2019

Feb 05, 2020
BUY
$49.21 - $64.19 $156,340 - $203,931
3,177 Added 66.12%
7,982 $512,000
Q3 2019

Oct 24, 2019
BUY
$42.77 - $50.71 $205,509 - $243,661
4,805 New
4,805 $244,000

Others Institutions Holding BMY

# of Institutions
2,536
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Foster & Motley Inc Portfolio

Follow Foster & Motley Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foster & Motley Inc, based on Form 13F filings with the SEC.

News

Stay updated on Foster & Motley Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email